The material on this site is for financial institutions, professional investors and their professional advisers. It is for information only. Please read our Terms & Conditions, Privacy Policy and Cookies before using this site. Please see our Subscription Terms and Conditions.

All material subject to strictly enforced copyright laws. © 2022 Euromoney, a part of the Euromoney Institutional Investor PLC.

SuperDerivatives forms alliance with S&P

Options specialist SuperDerivatives has signed an agreement with Standard & Poor’s Securities Evaluations to form a strategic sales and marketing alliance. The venture will provide valuations for a wide range of derivative contracts. The companies say their offering will help market participants manage their investment and operational risk and meet comply with regulatory requirements compliance more easily.


The joint offering will use both companies’ models and market data-based pricing services to provide independent valuations for arrange of instruments, including vanillas and exotics. “This commercial venture between SuperDerivatives and Standard & Poor’s Securities Evaluations is aimed at enabling our customers from developed and emerging markets to effectively value the widest range of products in a single offering,” says David Gershon, SuperDerivatives’ chief executive officer.

You have reached premium content. Please log in to continue reading.

Read beyond the headlines with Euromoney

For over 50 years, our readers have looked to Euromoney to stay informed about the issues that matter in the international banking and financial markets. Find out more about our different levels of access below.


Unlimited access to and

Expert comment, long reads and in-depth analysis interviews with senior finance professionals

Access the results of our market-leading annual surveys across core financial services

Access the results of our annual awards, including the world-renowned Awards for Excellence

Your print copy of Euromoney magazine delivered monthly

£73.75 per month

Billed Annually


Unlimited access to and, including our top stories, long reads, expert analysis, and the results of our annual surveys and awards

Sign up to any of our newsletters, curated by our editors


Already a user?

We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree